GSK PLC closed 13.65% below its 52-week high of £16.79, which the company achieved on September 9th.

SAN DIEGO, CA / ACCESS Newswire / June 18, 2025 / New endorsement signals growing momentum toward sustainability in pharmaceutical supply chains. My Green Lab®, the world's leading nonprofit ...

GSK GSK stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, ...

Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...

Identifying good mid cap stocks from hundreds of options is no easy feat. Luckily, we've done the hard work for you.

Britain's FTSE 100 rose on Wednesday as investors weighed positive inflation data ahead of key central bank meetings in the U ...

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

Based in Kuala Lumpur, Aman brings over two decades of HR experience across industries like finance and pharma. To him, ...

Hepatitis B is the most widespread serious liver infection globally, caused by the hepatitis B virus (HBV), which targets and damages the ...

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...